Status:
COMPLETED
Effect of Intraarticular Ozone, Prolotherapy or Dexmedetomidine in Pain Limitation in Knee Osteoarthritis
Lead Sponsor:
Tanta University
Conditions:
Intraarticular
Ozone
Eligibility:
All Genders
30-65 years
Phase:
NA
Brief Summary
This study aimed to compare intraarticular ozone injection, prolotherapy, or dexmedetomidine effectiveness in knee osteoarthritis patients.
Detailed Description
Osteoarthritis (OA) is a heterogeneous group of disorders of different etiologies with similar biological, morphological, and clinical manifestations and outcomes. The intraarticular injection has bee...
Eligibility Criteria
Inclusion
- Age from 30 to 65 years.
- Both genders.
- Patients diagnosed with stage 1-3 osteoarthritis according to the Kellgren-Lawrence Classification System (K-L).
Exclusion
- Patient refusal.
- History of knee trauma within the past month.
- Rheumatic disease.
- Pregnancy.
- Any surgical intervention of the knee.
- Severe cardiovascular disease.
- Morbid obese patients (body mass index (BMI) of \>35 kg/m2).
- Local infection at the site of injection.
- Bleeding diathesis.
Key Trial Info
Start Date :
October 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06909305
Start Date
October 1 2022
End Date
October 1 2023
Last Update
April 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tanta University
Tanta, El-Gharbia, Egypt, 31527